Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
& Galgani, J
Danones GLP-1 strategy: summary Danone targets GLP-1 users with whey-rich yoghurt supporting muscle health Microbiome focused medical nutrition aims to rebalance gut impacted by treatment Kate Farms offers high protein plant based shakes supporting satiety and muscle health Consumer and medical approaches expand opportunities as GLP-1 demand grows Launch timing and markets depend on regulation alignment and patient needs As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
You can also email us at [email protected] or call 888-988-8235 for immediate assistance
Provider Credentials, Medication Sourcing, and Safety Oversight Provider qualification and medication provenance significantly impact treatment safety
Key documents include your denial letter, sleep study report, OSA diagnosis/severity, BMI documentation, provider notes, and (recommended) a letter of medical necessity from your prescribing provider
US$ 24.91
US$ 20.75
US$ 28.15
